BRIAN STEVEN TAYLOR

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry VENTURA, CA NPI 1992905723

General Payments — all program years on this page

$2,387.39

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $329.89 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $329.8916

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ITI, Inc. $141.907
Lundbeck LLC $59.303
Sage Therapeutics, Inc. $33.332
ABBVIE INC. $31.091
Tempus AI, Inc $25.181
Neurocrine BioSciences, Inc. $20.141
IDORSIA PHARMACEUTICALS US INC $18.951

By program year

Program yearAmountRecords
2018 $163.613
2019 $352.705
2020 $107.005
2021 $266.7612
2022 $834.3828
2023 $333.057
2024 $329.8916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106205881 ABBVIE INC. $31.09 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120392409 Sage Therapeutics, Inc. $19.69 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120403574 Sage Therapeutics, Inc. $13.64 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331619 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.95 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331623 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.91 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331627 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.37 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331630 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.59 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331634 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.50 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331638 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.03 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143331642 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.55 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145974607 Lundbeck LLC $22.80 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145974609 Lundbeck LLC $15.43 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145974611 Lundbeck LLC $21.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146758230 IDORSIA PHARMACEUTICALS US INC $18.95 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150175600 Tempus AI, Inc $25.18 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150858323 Neurocrine Biosciences, Inc. $20.14 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.